EMA publishes details of new pharmacovigilance format
July 4, 2011Research and Development, Sales and Marketing EMA, pharmacovigilance
Pharma companies have been given the highly-specific electronic formats in which they will soon have to submit information on medicines …
A bigger conversation: taking market research online
July 4, 2011Medical Communications, Sales and Marketing digital, market research
The debate around pharma’s use of digital media has tended to focus on building relationships with patients or healthcare professionals …
Xarelto receives FDA approval
July 4, 2011Sales and Marketing Bayer, Eliquis, Johnson & Johnson, Pradaxa, Xarelto, anticoagulant
Bayer and Johnson & Johnson’s oral blood thinner Xarelto has been approved in the US for the prevention of deep …
Nycomed gains new European licence for cancer pain spray
July 4, 2011Sales and Marketing Nycomed, cancer pain, pain therapeutics
The European Commission has approved Nycomed’s Instanyl in a single-dose nasal spray for the treatment of breakthrough pain in cancer …
Reckitt Benckiser promotes Camillo Pane
July 4, 2011Sales and Marketing appointment, sales and marketing
Reckitt Benckiser’s UK general manager Camillo Pane has been promoted to senior vice president – global category officer healthcare. Reporting …
Digital Pharma: The Best of Health in digital
July 1, 2011Medical Communications Best of Health, Digital Pharma blog, awards, digital marketing, medical communications news
Recognition for digital pharma marketing has been slowly increasing over the last couple of years and last night’s Best of …
Lilly prepares late-stage pipeline boost
July 1, 2011Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology
Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …
EMA extends Avastin breast cancer licence
July 1, 2011Sales and Marketing avastin, breast cancer, metastatic breast cancer
The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …
Red Door promotes Katy Pogson
July 1, 2011Medical Communications appointment, medical communications
Katy Pogson has been promoted to associate director at Red Door Communications and joins its management team. She started at …
IPA Best of Health Awards – results
July 1, 2011Medical Communications Best of Health, IPA, awards, medical communications news
Langland and McCann Healthcare Sydney took home the highly coveted ‘Best of Show’ awards at the 2011 IPA Best of …
Almirall appoints new general manager for Germany
July 1, 2011Research and Development, Sales and Marketing Almirall, appointment, research and development, sales and marketing
Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …
Talentmark appoints Mark Johnson
June 30, 2011Business Services appointment, business services
Mark Johnson has joined London-based life science recruitment company Talentmark as a managing consultant. For the past eight years Mark …
AstraZeneca signs cancer drug discovery collaboration
June 30, 2011Research and Development AstraZeneca, PTC Therapeutics
AstraZeneca has signed a deal with PTC Therapeutics to use the company’s proprietary drug discovery platform to discover new cancer …
FDA advisers reject Avastin appeal
June 30, 2011Sales and Marketing FDA, avastin
An FDA advisory panel has refused to back Roche’s Avastin in advanced breast cancer after ruling it neither safe nor …
The growing role of regulatory affairs
June 30, 2011Business Services, Research and Development, Sales and Marketing regulatory affairs, topra
Some years ago, regulatory affairs (RA) was seen by some as merely a ‘front office’ function, providing a necessary interface …
Grindeks opens API plant in Latvia
June 30, 2011Manufacturing and Production Grindeks, pharma manufacturing news
Latvian pharmaceutical company Grindeks has opened a new active pharmaceutical ingredient (API) manufacturing plant that it predicts will add around …
Tarceva fails to win NICE backing
June 30, 2011Sales and Marketing NICE, Tarceva
NICE has decided not to recommend Roche’s Tarceva because of uncertainty over how long the lung cancer drug can extend …
GSK welcomes outside researchers to its ‘open lab’
June 29, 2011Research and Development GSK, TB, academic alliance, malaria, open lab
The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …
Janssen to collaborate with Jubilant on neuroscience targets
June 29, 2011Manufacturing and Production, Research and Development Janssen, Jubilant, neuroscience research
Janssen is to team up with Indian pharma services company Jubilant Life Sciences on neuroscience drug discovery. Jubilant Discovery Services …
New medicine approvals slumped to record low in 2010
June 29, 2011Research and Development, Sales and Marketing drug sales, new drug approvals, research
There was a major slide in medicine approvals last year, compounding a difficult and ominous period for the industry. Only …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
